All articles published in «Clinical Oncology» undergo thorough single-blind peer review. This involves review by two independent peer reviewers.Peer review policy
All submissions to «Clinical Oncology»journal are assessed by an Editor, who will decide whether they are suitable for peer review. Where an Editor is on the author list or has any other competing interest regarding a specific manuscript, another member of the Editorial Board will be assigned to assume responsibility for overseeing peer review. Submissions felt to be suitable for consideration will be sent for peer review by appropriate independent experts. Reviewers will be treated anonymously, and the pre-publication history of each article will not be made available online. Editors will make a decision based on the reviewers’ reports and authors are sent these reports along with the editorial decision on their manuscript. Authors should note that even in light of one positive report, concerns raised by another reviewer may fundamentally undermine the study and result in the manuscript being rejected.The final decision on whether to accept or reject a particular manuscript is taken by the editor. Before making a decision, the editor analyzes all the reviews and can ask the opinion of a third person or ask the author to correct the material.
Authors may request exclusion of individuals as peer reviewers, but they should explain the reasons in their cover letter on submission. Please note that the Editor may choose to invite excluded peer reviewers.
Intentionally falsifying information, for example, suggesting reviewers with a false name or e-mail address will result in rejection of the manuscript. «Clinical Oncology»takes seriously all allegations of potential misconduct. In cases of suspected research or publication misconduct, it may be necessary for the Editor to contact and share manuscripts with third parties, for example, author(s)’ institution(s) and ethics committee(s).
Statement of publishing ethics and malpractice
Reporting researches with human subjects, indicate whether the research procedures followed standards of local ethical committee on human experimentation (institutional or regional) or with the Helsinki Declaration (1964, amended in 2008) of the World Medical Association. If doubt exists local ethic review, approved the doubtful aspects of the study, must be presented.
The publications should be submitted only in case when patients presented written Informed Consent to participate and if local ethical committee approval of the study can be documented (presenting ethical approval). Patients have a right for privacy that should not be violated without informed consent. Identification of any information including patients’ names, initials, or hospital numbers is prohibited, especially in any illustrative material, except the cases when this information in extremely important from scientific point of view and patient presented Informed Consent to use this information.
When performing experiments on animals or animal tissues, authors should seek approval by local ethic committee and should strictly follow the institutional and national guide for the care and use of laboratory animals. At time of manuscript submission, authors should provide information on the study approval by local ethical committee.
The authors, reviewers, publishers and readers should communicate in polite and constructive manner.
Intentional assumption of authorship and data falsification are unacceptable.
Nonpublished data from submitted publications cannot be used in personal aims and transmitted to third persons without authors’ written consent. All information and ideas must stay confidential.
Authors are responsible for authenticity of the scientific data. Co-authors must be persons with remarkable contribution into submitted research.